Episodes

  • JVS Author Spotlight - Lenselink/Eefting, Lancaster/Mangipudi/Chang, Austin/Reichard/Muck

    JVS Author Spotlight - Lenselink/Eefting, Lancaster/Mangipudi/Chang, Austin/Reichard/Muck
    Oct 4 2026

    Audible Bleeding editor Wen Kawaji (@WenKawaji) is joined by Dr. Danielle Garcia, Dr. Robert Meyers, JVS editor Dr. Duncan (@ADuncanVasc), and JVS-VL editor Dr. Ruth Bush to discuss some of our favorite articles in the JVS family of journals.

    Articles:

    • Closed incisional negative pressure wound therapy vs standard surgical dressing for groin incisions following arterial vascular surgery: A prospective multicenter randomized clinical trial

    • When to Stop: Optimizing Abdominal Aortic Aneurysm Surveillance in the Elderly

    • Adding Artificial Intelligence to the PERT Improves Time to Diagnosis and Treatment of Pulmonary Embolism

    Show Guests

    • Ellie Lenselink, clinical nurse specialist working at The Wound Expertise Clinic in Hague, Netherlands. Her clinical and research focus is wound healing, particularly wounds associated with vascular disease, diabetic foot disease and surgery. She completed a Master of Science in Wound healing and Tissue Repair at Cardiff University. She is one of the driving forces behind establishing HMC's multidisciplinary Wound Expert Clinic, integrating clinical wound care with research. She currently serves on the Editorial Board of the International Wound Journal.

    • Dr. Daniel Eefting, MD, PhD is a vascular surgeon affiliated with Hague Medical Center and Leiden University Medical Center (LUMC). He has extensive research contributions with work centered on vascular surgery, peripheral arterial disease, wound healing, vascular access, aortic disease and endovascular techniques.

    • Dr. Robert Chang is the Assistant Chair of Vascular Surgery for The Permanente Medical Group, an adjunct investigator with the Kaiser Permanente Division of Research and has a clinical vascular surgery practice based in the Bay Area.

    • Dr. Elizabeth Lancaster is a San Francisco based Vascular Surgeon currently employed by the Kaiser Permanente Medical Group. She earned her MD at UCLA and completed General Surgery residency and Vascular Surgery Fellowship at UCSF

    • Dr. Sowmya Mangipudi is a current resident and on an implementation Science T32 at UCSF and is a former NIH-Fogarty Fellow. She received my MD at GW and her Masters of Science in Global Health & Surgery from Kings College London

    • Dr. Emily Austin is a recent graduate of the TriHealth Integrated Vascular surgery residency in Cincinnati. She earned her MD from the University of Alabama in Birmingham and has joined the Montgomery Vascular Surgery group

    • Dr. Patrick Muck is the Section Chief of the Department of Vascular Surgery and Director of the vascular fellowship at TriHealth. He earned his MD from University of Kentucky and attended residency and fellowship at Good Samaritan Hospital. He is immediate past president of the Midwestern Vascular Surgical Society

    • Dr. Adam Reichard is the Co-director of the TriHealth Heart and Vascular Comprehensive Aortic Center. He earned his MD from St. George's University in Grenada and attended residency and fellowship at TriHealth – Good Samaritan Hospital

    Follow us @audiblebleeding

    Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

    *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.
    Show More Show Less
    1 hr and 9 mins
  • JVS Author Spotlight - Wei, Woo & Zielasek

    JVS Author Spotlight - Wei, Woo & Zielasek
    Sep 17 2026

    Audible Bleeding Editor and vascular surgery fellow Sasank Kalipatnapu (@ksasank) is joined by James Martinson, a practicing general surgeon with an interest in vascular surgery, currently serving as the ship's surgeon for the USS John F. Kennedy aircraft carrier; JVS editor Dr. Audra Duncan (@ADuncanVasc); and JVS-CIT editor Dr. Matthew Smeds (@MattSmeds) to discuss two great articles in the JVS family of journals.

    Articles:

    • Part 1: The association between multimorbidity and arteriovenous fistula creation outcomes (Wei and Woo)

    • Part 2: In Vitro fEVAR Deployment and Cannulation Using an Electromagnetically Steerable Guidewire (Zielasek)

    Show Guests:

    • Dr. Melissa Wei (@melissaywei) is a professor of medicine at the David Geffen School of Medicine in UCLA within the Division of Internal Medicine and Health Services Research (LinkedIn)

    • Dr. Karen Woo is a professor of surgery at the David Geffen School of Medicine in UCLA, and as a practicing vascular surgeon, she has authored over 100 peer-reviewed articles, focusing on improving dialysis access outcomes (UCLA)

    • Dr. Christian Zielasek is a practicing vascular surgeon in Switzerland at the University Hospital of Bern (ResearchGate)

    Follow us @audiblebleeding

    Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

    *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.
    Show More Show Less
    59 mins
  • Inside the Editorial: This Signal Brings Noise

    Inside the Editorial: This Signal Brings Noise
    Sep 21 2026

    Jacob Soucy (@JacobWSoucy) hosts an inside look at a timely and thought-provoking editorial published in The Vascular Specialist, the official news magazine of the Society for Vascular Surgery.

    In this episode, we explore the introduction of preference signaling to the integrated vascular surgery match through the lens of the editorial "This Signal Brings Noise." The discussion examines whether signaling addresses problems that exist within the vascular surgery match, how signals may influence interview selection, and the potential unintended consequences of introducing artificial scarcity into an already highly successful match process.

    Jacob speaks with Dr. Malachi G. Sheahan III about the motivation behind the piece, the problems preference signaling is intended to solve, how applicants and programs may approach the new system, and why signaling may turn the application process into a strategic game. They also discuss application review, virtual versus in-person interviews, the role of program reputation and mentorship in applicant decision-making, and what the vascular surgery community should watch as signaling is implemented for the first time.

    Show Guest

    Dr. Malachi G. Sheahan III is Professor and Chair of Surgery at Louisiana State University Health Sciences Center and Chief of the Division of Vascular Surgery. He previously served as Program Director for both the fellowship and integrated residency in vascular surgery at LSU. Nationally, Dr. Sheahan serves as Secretary of the Society for Vascular Surgery and as Chief Medical Editor of The Vascular Specialist. With more than two decades in academic surgery, he is a recognized leader in vascular education, workforce policy, and advocacy within the specialty.

    Resources and Social Media

    X (Twitter): @lsuvascular

    Read the editorial: "This Signal Brings Noise" – The Vascular Specialist

    Special thanks to Dr. Malachi G. Sheahan III for sharing his time and perspective on preference signaling and its potential impact on vascular surgery applicants, programs, and the match.

    Follow us @audiblebleeding for updates on upcoming episodes and new research features. Learn more about us at audiblebleeding/about and share your feedback through our listener survey.

    *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.
    Show More Show Less
    26 mins
  • JVS Author Spotlight - Hamouda, Malas, Lohr, & Dua

    JVS Author Spotlight - Hamouda, Malas, Lohr, & Dua
    Aug 9 2026

    Audible Bleeding Editor and vascular surgery fellow Richa Kalsi (@KalsiMD) is joined by James Martinson, practicing general surgeon with an interest in vascular surgery currently serving as the ship's surgeon for the USS Harry S Truman aircraft carrier and Langford Green (@langfordgreen_), research fellow at the Center for Vascular Research at the University of Maryland currently applying to medical school, JVS editor Dr. Audra Duncan (@ADuncanVasc), and JVS-VI editor Dr. Anahita Dua (@AnahitaDua) to discuss two great articles in the JVS family of journals.

    Articles:

    • Part 1: Open bypass versus endovascular therapy in chronic limb-threatening ischemia patients with prior endovascular attempts (Hamouda & Malas)

    • Part 2: Retrospective review of 3126 patients with chronic lower extremity wounds treated with intermittent topical oxygen therapy (Lohr & Dua)

    Show Guests

    • Dr. Mohammed Hamouda was a postdoctoral research fellow at UC San Diego, Division of Vascular & Endovascular Surgery, and an incoming integrated vascular surgery resident at the Houston Methodist Hospital (LinkedIn)

    • Dr. Mahmoud Malas is the chief of vascular and endovascular surgery at UC San Diego, and the vice chair of surgery for clinical research at UC San Diego School of Medicine (@malas_mahmoud)

    • Dr. JoAnn Lohr is a vascular surgeon with her own practice in Cincinnati, OH, and has also worked in the VA system of Columbia, SC (LinkedIn)

    Follow us @audiblebleeding

    Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

    *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.
    Show More Show Less
    53 mins
  • Landmark Paper Series: Abdominal Aortic Aneurysm

    Landmark Paper Series: Abdominal Aortic Aneurysm
    Aug 2 2026

    Welcome back to the Audible Bleeding Series: Landmark Papers in Vascular Surgery. In this episode, Audible Bleeding editor John Culhane and co-host Dr. Jesse Columbo are joined by our guests, Dr. David Stone, Dr. Salvatore Scali, and Dr. Anders Wanhainen to unpack one of the longest-running debates in aortic surgery: when (and whether) to repair an abdominal aortic aneurysm.

    We'll start our episode with the open-repair era and the two trials that set the basis for the 5.5 cm threshold—UKSAT and ADAM—then move into the early EVAR years with PIVOTAL and CAESAR, which asked whether fixing smaller aneurysms with endovascular technology could do better. Finally, we'll look at how modern screening programs, improved medical therapy, and current guidelines have reshaped the practical decisions we make for these patients every day.

    Links to Papers Discussed:

    Open Surgery Era

    1. UKSAT (1998)

    2. ADAM (2002)

    Endovascular Era

    1. PIVOTAL (2010)

    2. CAESAR (2012)

    Contemporary Results

    1. Oliver-Williams/NHS NAAASP

    2. Rokosh/SVS Guidelines

    3. ESVS 2026 Guidelines

    Guests:

    Dr. David Stone, MD (@DHStoneMD); Dartmouth

    Dr. Salvatore Scali, MD (@UFVascular); University of Florida

    Dr. Anders Wanhainen, MD, PhD (@AWanhainen); Uppsala University, Sweden

    Hosts:

    John Culhane, MD (@JohnCulhaneMD); Vascular Surgery Fellow, Montefiore

    Dr. Jesse Columbo, MD; Dartmouth

    Follow us @audiblebleeding,

    Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

    *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.
    Show More Show Less
    50 mins
  • JVS CIT Abstracts & Editorials - June 2026

    JVS CIT Abstracts & Editorials - June 2026
    Jul 21 2026

    In this episode, we spotlight editorials and abstracts from the Journal of Vascular Surgery Cases, Innovations, and Techniques (JVS-CIT). Editorials and Abstracts are read by Authors as well as members of the SVS Social Media Ambassadors.

    Guests:

    Isabel Banks, MS4, SLU

    1. Best of 2025 - rare, high-risk, and unforgettable vascular cases

    2. Best of 2025: Venous disease

    3. Hemodynamic and patient-level considerations in inferior mesenteric artery aneurysm management

    4. Reply

    5. Ultra-distal bypass remains a valuable option for tibial disease with tissue loss

    6. Stewart Treves syndrome as a catastrophic sequela of chronic lymphedema: Clinical spectrum, management challenges, and outcomes

    7. The best of 2025 - peripheral and splanchnic aneurysms and mesenteric vascular disease

    Hosts:

    John Culhane (@JohnCulhaneMD)

    Follow us @audiblebleeding, @JVS-CIT

    Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

    *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.
    Show More Show Less
    48 mins
  • Holding Pressure - TransCarotid Artery Revascularization (TCAR)

    Holding Pressure - TransCarotid Artery Revascularization (TCAR)
    Jun 24 2026
    CORE RESOURCES: Rutherford's Vascular and Endovascular Therapy 10th Edition, Chapters 88, 89, 91, and 94 Atlas of Vascular Surgery and Endovascular Therapy 2nd Edition, Chapter 9 ADDITIONAL RESOURCES: Audible Bleeding Episodes Holding Pressure - Carotid Endarterectomy: https://www.audiblebleeding.com/2024/02/27/holding-pressure-carotid-endarterectomy/ Holding Pressure Case Prep - Endovascular Basics: https://www.audiblebleeding.com/2023/04/23/holding-pressure-case-prep-endovascular-basics/ Videos TCAR Technical Video: https://jnis.bmj.com/content/14/8/842 Articles Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease: https://www.jvascsurg.org/article/S0741-5214%2821%2900893-4/fulltext Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid neuroprotection and stent system: https://www.jvascsurg.org/action/showPdf?pii=S0741-5214%2816%2931862-6 Referenced Studies ROADSTER-1 https://pubmed.ncbi.nlm.nih.gov/30611582/ ROADSTER-2 https://pubmed.ncbi.nlm.nih.gov/32811386/ https://pubmed.ncbi.nlm.nih.gov/35381327/ TCAR Surveillance Project https://jamanetwork.com/journals/jama/fullarticle/2757579?utm_source=openevidence&utm_medium=referral https://pubmed.ncbi.nlm.nih.gov/36172943/ OUTLINE: CAROTID ARTERY DISEASE 1. Pathophysiology/etiology Carotid artery disease is primarily driven by atherosclerotic plaque deposition. Risk factors: hypertension, hyperlipidemia, diabetes, smoking, and advanced age. Nonatherosclerotic etiologies: fibromuscular dysplasia, carotid dissection, vasculitic disease, carotid webs, and trauma. When the endothelium is damaged, monocytes migrate to the site and differentiate into macrophages that take up oxidized LDL particles to become foam cells. Meanwhile, an inflammatory response occurs where activated platelets release thromboxane A2, platelet derived growth factor, and inflammatory cytokines that promote further platelet aggregation and vascular inflammation. Smooth muscle cells migrate and proliferate, forming the structural framework of the atheroma. Within the lesion, necrotic debris and lipid accumulate, creating a vulnerable plaque. Plaque rupture exposes this material to the bloodstream, serving as a nidus for thrombus formation which can lead to ischemic events. Carotid bifurcation is particularly prone to plaque formation due to turbulent blood flow. Embolization of plaque from this area can result in TIA or ischemic stroke. 2. Presentation Patients are often asymptomatic and stenosis is incidentally found on imaging. Symptomatic patients present with neurologic symptoms including unilateral motor and sensory loss, aphasia (difficulty finding words), dysarthria (difficulty speaking), amaurosis fugax (temporary monocular vision loss due to embolus to the ophthalmic artery), transient ischemic attacks Physical exam findings may be notable for auscultation of a carotid bruit. Patients may also have evidence of retinal artery embolization on fundoscopic examination (Hollenhorst plaque) or asymptomatic cerebral infarction. 3. Diagnosis USPTF recommends against screening for asymptomatic carotid artery stenosis. In patients with no risk factors, SVS recommends against screening for asymptomatic carotid artery stenosis. However, they do recommend screening for asymptomatic clinically significant carotid bifurcation in certain groups of patients with multiple risk factors. These risk factors include patients with clinically significant peripheral vascular disease, patients 65 and older with history of CAD, smoking, hypercholesterolemia, and patients prior to coronary artery bypass. Relevant findings on physical exam or imaging findings may warrant screening, but screening is not recommended for the presence of neck bruit alone without other risk factors, as this finding has a low sensitivity and specificity for detecting clinically significant carotid artery stenosis. Carotid duplex ultrasound: first-line imaging modality for both screening and initial evaluation of stenosis, noninvasive, low-cost CTA: rapid, high-resolution, three-dimensional imaging of vascular anatomy, risk of contrast and radiation exposure MRA: high-quality, three-dimensional imaging without radiation or contrast, expensive with longer acquisition time, can overestimate stenosis in severe disease DSA/angiography: gold standard, expensive, invasive, not generally recommended for routine diagnostic evaluation or screening 4. Classification Carotid artery stenosis is classified by degree of luminal narrowing. NASCET method: standard in current practice. Compares the minimal residual lumen at the point of greatest stenosis to the diameter of the normal distal internal carotid artery. Classification of stenosis: Mild: <50% narrowing Moderate: 50-69% narrowing Severe: ≥70% narrowing TRANSCAROTID ARTERY REVASCULARIZATION (TCAR) 5. ...
    Show More Show Less
    34 mins
  • Landmark Paper Series: Asymptomatic Carotid Artery Stenosis

    Landmark Paper Series: Asymptomatic Carotid Artery Stenosis
    May 31 2026

    Welcome back to the Audible Bleeding series: Landmark Papers in Vascular Surgery. In this episode, co-hosts John and Dr. Jesse Columbo are joined by our guest, Dr. Caitlin Hicks, to discuss one of the most studied—and most debated—topics in vascular surgery: asymptomatic carotid stenosis.

    In this episode, we'll trace that evolution through three pivotal trials: ACAS and ACST-1, which established carotid endarterectomy as the standard of care; and the newly published CREST-2, which challenges us to reconsider everything we thought we knew. Along the way, we'll explore how advances in statin therapy, blood pressure control, and antiplatelet agents have fundamentally changed the natural history of this disease—and what that means for our patients today."

    Links to Landmark Papers:

    1. (ACAS) Endarterectomy for Asymptomatic Carotid Artery Stenosis

    1. (ACST-1) 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis: a multicentre randomised trial

    1. (CREST-2) Medical Management and Revascularization for Asymptomatic Carotid Stenosis

    Guests:

    Dr. Caitlin Hicks, MD (@CaitlinWHicks); Associate Fellowship Program Director, Vascular Surgery & Endovascular Therapy at Johns Hopkins and Director of Research

    Hosts:

    John Culhane, MD (@JohnCulhaneMD); General Surgery Resident, Abrazo Health

    Dr. Jesse Columbo, MD; Assistant Professor of The Dartmouth Institute, Geisel School of Medicine, Dartmouth



    Follow us @audiblebleeding,

    Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

    *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

    Show More Show Less
    34 mins